|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/25 | |
| A61P 9/00 | |||
| A61P 17/00 |
| (11) | Patento numeris | 2310041 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 09761776.5 |
| Europos patento paraiškos padavimo data | 2009-06-12 | |
| (97) | Europos patento paraiškos paskelbimo data | 2011-04-20 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2013-02-13 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2009/057263 |
| Data | 2009-06-12 |
| (87) | Numeris | WO 2009/150214 |
| Data | 2009-12-17 |
| (30) | Numeris | Data | Šalis |
| 61163 P | 2008-06-13 | US |
| (72) |
BRIZZI, Maria Felice, IT
MUCCIOLI, Giampiero, IT
GHIGO, Ezio, IT
|
| (73) |
ALIZE PHARMA,
15, Chemin Du Saquin, Espace Europeen, 69130 Ecully,
FR
|
| (54) | UNACYLATED GHRELIN AND ANALOGS AS THERAPEUTIC AGENTS FOR VASCULAR REMODELING IN DIABETIC PATIENTS AND TREATMENT OF CARDIOVASCULAR DISEASE |
| UNACYLATED GHRELIN AND ANALOGS AS THERAPEUTIC AGENTS FOR VASCULAR REMODELING IN DIABETIC PATIENTS AND TREATMENT OF CARDIOVASCULAR DISEASE |